Despite great scientific advances over the past decade, the translation of these discoveries to the benefit of patients has been hampered by a number of traditional barriers. The overall goal of the iWioyinit Siimai ImstitiLiiites of ClBrnical &Tiramslatioinial Sciences is to establish a new research paradigm at Mount Sinai, which will create an integrated multidisciplinary environment that will enable translation of cutting-edge research more quickly and easily from """"""""bench-to-bedside-to-implementation"""""""" in the community;train and create an """"""""academic home"""""""" for the clinical and translational investigators of tomorrow;and supply the governance, facilities, resources and opportunities needed to elevate the clinical research enterprise so that clinical investigators can take full advantage of Mount Sinai's Translational Research Institutes and potential collaborators in Mount Sinai Hospital and its affiliates, the School of Medicine and partnering institutions, and other CTSA programs around the country. This transformation will be achieved by fulfilling the following Specific Aims: (1) redesign the institutional research enterprise infrastructure and governance by integrating research functions across administrative, departmental and intellectual boundaries, enhancing and promoting interactions between basic scientists and clinical investigators, and streamlining administrative procedures to facilitate the start-up of clinical trials and the dissemination of results;(2) establish a Translational Discoveries Program to facilitate and expedite clinical research by providing consultation, oversight and facilities for clinical and translational research, engaging the surrounding community and our affiliates to rapidly translate health benefits to the general population, and developing new methodologies to improve clinical trial design and reduce participant burden;(3) train and support the translational investigators of tomorrow by overseeing a multi-disciplinary, doctoral degree-granting program in clinical and translational research for all health care professionals, developing a program to recruit, enhance career development and retain clinical and translational researchers, providing an academic home where new collaborations can be formulated;(4) establish an Experimental Therapeutics&Technologies Program to stimulate the development of new methodologies in clinical and translational research by developing an institution-wide mentored program to identify and develop novel clinical and translational research projects; and (5) establish an institution-wide biomedical information infrastructure that can connect basic researchers, clinical researchers, caregivers and laboratories with an integrated network of information.

Public Health Relevance

The establishment of the ilfloynt Siinao Institutes of Clinical &Tiranslational Sciemces would create an effective, efficient and centralized research administrative structure, foster and reward interdisciplinary collaborations, educate and retain the clinical and translational investigators of the future, enable translation of basic scientific discoveries into clinical practice, and deliver to our diverse community new therapies and a standard of care that would have been unimaginable even five years ago.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Mentored Career Development Award (KL2)
Project #
3KL2TR000069-05S1
Application #
8845358
Study Section
Special Emphasis Panel (ZRR1-CR-1 (02))
Program Officer
Merchant, Carol
Project Start
2009-07-14
Project End
2015-03-31
Budget Start
2014-05-16
Budget End
2015-03-31
Support Year
5
Fiscal Year
2014
Total Cost
$181,393
Indirect Cost
$53,077
Name
Icahn School of Medicine at Mount Sinai
Department
Pediatrics
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Nowak-W?grzyn, Anna; Lawson, Kaitie; Masilamani, Madhan et al. (2018) Increased Tolerance to Less Extensively Heat-Denatured (Baked) Milk Products in Milk-Allergic Children. J Allergy Clin Immunol Pract 6:486-495.e5
Srivastava, K D; Song, Y; Yang, N et al. (2017) B-FAHF-2 plus oral immunotherapy (OIT) is safer and more effective than OIT alone in a murine model of concurrent peanut/tree nut allergy. Clin Exp Allergy 47:1038-1049
Kale, Minal S; Mhango, Grace; Gomez, Jorge E et al. (2017) Treatment Toxicity in Elderly Patients With Advanced Non-Small Cell Lung Cancer. Am J Clin Oncol 40:470-476
Stern, Emily R; Muratore, Alexandra F; Taylor, Stephan F et al. (2017) Switching between internally and externally focused attention in obsessive-compulsive disorder: Abnormal visual cortex activation and connectivity. Psychiatry Res Neuroimaging 265:87-97
Srivastava, Kamal D; Siefert, Alyssa; Fahmy, Tarek M et al. (2016) Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy. J Allergy Clin Immunol 138:536-543.e4
Lucas, Aimee L; Bravi, Francesca; Boffetta, Paolo et al. (2016) Adherence to World Cancer Research Fund/American Institute for Cancer Research recommendations and pancreatic cancer risk. Cancer Epidemiol 40:15-21
Amin, S; Mhango, G; Lin, J et al. (2016) Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis. Am J Gastroenterol 111:1350-7
Schneier, Amanda; Stueck, Ashley E; Petersen, Bruce et al. (2016) An Unusual Cause of Acute Liver Failure: Three Cases of Hemophagocytic Lymphohistiocytosis Presenting at a Transplant Center. Semin Liver Dis 36:99-105
Hernandez, Yasmin G; Lucas, Aimee L (2016) MicroRNA in pancreatic ductal adenocarcinoma and its precursor lesions. World J Gastrointest Oncol 8:18-29
Lucas, Aimee L; Bosetti, Cristina; Boffetta, Paolo et al. (2016) Dietary total antioxidant capacity and pancreatic cancer risk: an Italian case-control study. Br J Cancer 115:102-7

Showing the most recent 10 out of 44 publications